NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
BILCARE LTD. (BSE: 526853)
526853 Technical Analysis
4
As on 24th Dec 2024 526853 SHARE Price closed @ 58.86 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 72.08 & Sell for SHORT-TERM with Stoploss of 61.06 we also expect STOCK to react on Following IMPORTANT LEVELS. |
526853SHARE Price
Open | 56.26 | Change | Price | % |
High | 60.99 | 1 Day | 3.70 | 6.71 |
Low | 55.19 | 1 Week | 0.83 | 1.43 |
Close | 58.86 | 1 Month | 0.83 | 1.43 |
Volume | 36471 | 1 Year | -19.08 | -24.48 |
52 Week High 95.40 | 52 Week Low 54.01 |
BSE INDIA Most Active Stocks
532822 | 7.47 | -0.13% |
532411 | 0.41 | 0.00% |
517001 | 0.09 | 12.50% |
511700 | 1.01 | -0.98% |
512149 | 0.88 | 0.00% |
511389 | 7.25 | -2.42% |
534690 | 7.65 | 4.79% |
532775 | 2.04 | -0.97% |
531328 | 1.05 | 0.96% |
532648 | 19.80 | -0.60% |
BSE INDIA Top Gainers Stocks
BSE INDIA Top Losers Stocks
526853 Daily Charts |
526853 Intraday Charts |
Whats New @ Bazaartrend |
526853 Free Analysis |
|
526853 Important Levels Intraday
RESISTANCE | 70.04 |
RESISTANCE | 66.45 |
RESISTANCE | 64.24 |
RESISTANCE | 62.02 |
SUPPORT | 55.70 |
SUPPORT | 53.48 |
SUPPORT | 51.27 |
SUPPORT | 47.68 |
526853 Target February 2025
4th UP Target | 0 |
3rd UP Target | 0 |
2nd UP Target | 0 |
1st UP Target | 0 |
1st DOWN Target | 0 |
2nd DOWN Target | 0 |
3rd DOWN Target | 0 |
4th DOWN Target | 0 |
526853 Weekly Target
4th UP Target | 0.00 |
3rd UP Target | 0.00 |
2nd UP Target | 0.00 |
1st UP Target | 0.00 |
1st DOWN Target | 0.00 |
2nd DOWN Target | 0.00 |
3rd DOWN Target | 0.00 |
4th DOWN Target | 0.00 |
526853 Target2025
4th UP Target | 185.09 |
3rd UP Target | 151.08 |
2nd UP Target | 130.05 |
1st UP Target | 109.03 |
1st DOWN Target | 49.03 |
2nd DOWN Target | 28.01 |
3rd DOWN Target | 6.98 |
4th DOWN Target | -27.03 |
BILCARE LTD. ( BSE INDIA Symbol : 526853 )
Sector : Other And Other Stocks in Same Sector
Sector : Other And Other Stocks in Same Sector
526853 Other Details
Segment | EQ | |
Market Capital | 1090142720.00 | |
Sector | Other | |
Industry | Other | |
Offical website | > echo $website ; ?> |
526853 Address
![]() |
526853 Latest News
526853 Business Profile
Bilcare Limited provides pharmaceutical packaging research solutions and global clinical services in India and internationally. The company offers various specialty polymer films and aluminum foils primarily used for packaging solid dosage pharmaceutical products; and other packaging films solutions for applications in ID card, specialty film, and food packaging industries. It also provides clinical trial materials supplies and project management services; and nonClonableID, an anti-counterfeiting, security, and brand protection solution for various industry sectors. The company serves pharmaceutical and biotechnology industries. Bilcare Limited was incorporated in 1987 and is based in Pune, India. Address: 601, ICC Trade Tower, Pune, India, 411016
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service